Agilon Health
194 hedge funds and large institutions have $260M invested in Agilon Health in 2025 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 50 increasing their positions, 59 reducing their positions, and 44 closing their positions.
2,259% more call options, than puts
Call options by funds: $637K | Put options by funds: $27K
20% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 44
2% more funds holding
Funds holding: 190 → 194 (+4)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.1% less ownership
Funds ownership: 3.74% → 3.64% (-0.1%)
15% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 59
35% less capital invested
Capital invested by funds: $400M → $260M (-$139M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$10.3M |
| 2 |
D.E. Shaw & Co
New York
|
+$8M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$7.37M |
| 4 |
NPCM
North Peak Capital Management
New York
|
+$2.88M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.9M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$8.48M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.63M |
| 4 |
Morgan Stanley
New York
|
-$4.27M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.98M |
AGL Hedge Fund Activity: Q4 2025 in Review
194 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q4 2025, worth a combined $260M — down 35% from $400M a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new AGL positions and 44 closed out — a net gain of 9 holders — while 50 added to existing stakes and 59 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $10.3M. The largest seller was Fidelity Investments, cutting an estimated $9.9M.
- 194 institutional investors held Agilon Health (AGL) as of Q4 2025, up from 190 in Q3 2025.
- Funds reported $260M of Agilon Health stock for Q4 2025, down 35% quarter-over-quarter.
- 53 funds opened new Agilon Health positions in Q4 2025 and 44 closed out, a net change of +9 holders.
- The largest Agilon Health buyer in Q4 2025 was Goldman Sachs, an estimated $10.3M added.
- The largest Agilon Health seller in Q4 2025 was Fidelity Investments, an estimated $9.9M sold.
Based on aggregated 13F filings for Q4 2025.